Exegenesis Bio
Exegenesis Bio is a clinical-stage global cell and gene therapy company with a mission to develop the most advanced one-time curative gene and cell therapies for patients worldwide. With a strong financial backing and fully integrated manufacturing capabilities, the company operates in Philadelphia, Boston, China, and Singapore, focusing on three initial therapeutic areas: CNS, ophthalmology, and liver-directed diseases.
Founded in 2019, Exegenesis Bio utilizes innovative platforms such as AAVarta for AAV capsid evolution, Constellation for AI-aided DNA expression cassette design, and data-driven protein engineering to reimagine gene therapy. Committed to efficiency, excellence, ownership, and putting people first, the company aims to transform science into cures and increase access to gene and cell therapies globally.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.